MAGIA2Market follows on from the first phase of the MAGIA project which ended on December 31, 2019. The second phase, MAGIA2MArket, once again brings together the four main European MedTech clusters: bioPmed (coordinator, Piedmont), BioWin (Wallonia), Life Science Nord (Northern Germany) and Lyonbiopole (Auvergne-Rhône-Alpes) who are joining forces to pursue...
Read More
MAGIA, The European MedTech Alliance dedicated to supporting the internationalization of SMEs, brings together 4 poles of excellence: Lyonbiopôle (France), BioPmed (Italy), BioWin and Life Science Nord (Germany), and aims to achieve a solid and reciprocal understanding of the activities of the four clusters in order to strengthen their collaboration. In this context, each...
Read More
For the cluster, S3MartMed constitutes an opportunity to develop a partnership with 4 other European clusters of excellence - BioPmed (Italy), BioRegio STERN Management (Germany), Lyonbiopôle (France) and MedSilesia (Poland) - in order to identify in the medical technology sector: Future key investment priorities, Joint activities for the emergence of interregional collaborations (commercial...
Read More
The project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector, was selected to receive funding under the EU COSME “European Cluster Excellence” initiative. MAIN OBJECTIVE The project aims to foster cluster collaboration on a European-wide scale. The ultimate objective is to strengthen both, clusters and SMEs, to...
Read More